news
Mike Harley Appointed Chief Franchisor Officer
Galt Phranchise™ System announces Mike Harley as Chief Franchisor Officer, bringing over 40 years of franchise development expertise to lead GPS expansion efforts.
Read More
News & Blog
Stay informed with the latest updates and insights from Galt Phranchise™ System
All Posts
news
Galt Founders Named EY Entrepreneur of the Year Finalists
Galt Companies co-founders recognized among the region's most innovative and impactful entrepreneurs for their groundbreaking work in pharmaceutical franchising and non-opioid pain management solutions.
Read More
blog
Rising Stronger: Celebrating the Galt Journey
Reflecting on our journey, celebrating our achievements, and looking forward to an exciting future of growth and innovation in pharmaceutical franchising.
Read More
blog
The Galt Franchise Model: What It Takes to Succeed
Discover what qualities make successful Galt franchisees and learn about the benefits of owning a Galt franchise territory in the pharmaceutical industry.
Read More
blog
Quality over Quantity
Exploring why quality relationships with healthcare providers matter more than volume in pharmaceutical sales and how the Galt Way prioritizes meaningful partnerships.
Read More
blog
Simplifying the Prescribing Process
Learn how Galt Pharmaceuticals streamlines the prescribing process to minimize provider burden and maximize patient access through innovative support systems.
Read More
blog
Revolutionizing the Pharmaceutical Landscape
Discover how pharmaceutical franchise businesses are transforming the industry, empowering entrepreneurs, and democratizing access to healthcare innovation.
Read More
blog
The Galt Sales Process: An Inch Wide and A Mile Deep
Discover how the Galt Sales Process flips the traditional pharmaceutical sales model on its head by going a mile deep and an inch wide, building meaningful relationships instead of superficial transactions.
Read More
news
Galt Expands Pain Portfolio with Tolectin DS®
Galt Pharmaceuticals proudly announces the introduction of Tolectin DS® (Tolmetin Sodium 400mg Capsules) to its growing non-opioid pain product portfolio.
Read More
